Saturday, July 11, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “formulation”

865 pharma patents match "formulation" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 865
Index total 30,257
Page 23 / 37

Quick answer

This filtered view shows 865 pharmaceutical patents matching "formulation" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

865 results for “formulation” · 30,257 patents in full index Clear search

  1. US 9914763

    VEGF antagonist formulations suitable for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

  2. US 9913869

    Formulations comprising herbal extracts

    MONTERO GIDA SANAYI VE TICARET A.S. · Granted Mar 13, 2018 · Expires Mar 8, 2038

    granted

  3. US 9878031

    Compositions, methods of administration and uses for trivalent dengue virus formulations

    Takeda Vaccines, Inc. · Granted Jan 30, 2018 · Expires Jan 25, 2038

    granted

  4. US 9867876

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 16, 2018 · Expires Jan 11, 2038

    granted

  5. US 9861691

    Norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  6. US 9861695

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Jan 9, 2018 · Expires Jan 4, 2038

    granted

  7. US 9856475

    Formulations for treating amyloidosis

    ARCTURUS THERAPEUTICS, INC. · Granted Jan 2, 2018 · Expires Dec 28, 2037

    granted

  8. US 9849133

    Pharmaceutical formulations of xanthine or xanthine derivatives, and their use

    Eton Pharmaceuticals, Inc. · Granted Dec 26, 2017 · Expires Dec 21, 2037

    granted

  9. US 9840483

    Radiomitigating pharmaceutical formulations

    The Regents of the University of California · Granted Dec 12, 2017 · Expires Dec 7, 2037

    granted

  10. US 9833410

    Lyophilized formulation comprising GM-CSF neutralizing compound

    TAKEDA GMBH · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  11. US 9833406

    Lubricant formulations

    Reoxcyn Discoveries Group, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  12. US 9833460

    Pharmaceutical formulation

    Semnur Pharmaceuticals, Inc. · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  13. US 9833427

    Creatine ester anti-inflammatory compounds and formulations

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Dec 5, 2017 · Expires Nov 30, 2037

    granted

  14. US 9820966

    Stabilized statin formulations

    Cumberland Pharmaceuticals Inc. · Granted Nov 21, 2017 · Expires Nov 16, 2037

    granted

  15. US 9808465

    Emulsion formulations of aprepitant

    Heron Therapeutics, Inc. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  16. US 9808525

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Nov 7, 2017 · Expires Nov 2, 2037

    granted

  17. US 9801813

    Preservative-free ophthalmic pharmaceutical formulation

    SENTISS PHARMA PRIVATE LIMITED · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  18. US 9801942

    Etanercept formulations stabilized with metal ions

    Coherus BioSciences, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  19. US 9801934

    Parenteral norovirus vaccine formulations

    Takeda Vaccines, Inc. · Granted Oct 31, 2017 · Expires Oct 26, 2037

    granted

  20. US 9795567

    Immediate release formulations and dosage forms of gamma-hydroxybutyrate

    Jazz Pharmaceuticals, Inc. · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  21. US 9795592

    Pharmaceutical formulations of vildagliptin

    SANOVEL ILAC SANAYI VE TICARET ANONIM SIRKETI · Granted Oct 24, 2017 · Expires Oct 19, 2037

    granted

  22. US 9789185

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 17, 2017 · Expires Oct 12, 2037

    granted

  23. US 9782479

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

  24. US 9782480

    Stable aqueous formulations of adalimumab

    Coherus BioSciences, Inc. · Granted Oct 10, 2017 · Expires Oct 5, 2037

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.